RESEARCH ARTICLES

 

Screening of four Cyclopia (honeybush) species for putative phyto-oestrogenic activity by oestrogen receptor binding assays

 

 

N.J.D. Verhoog^I; E. Joubert^II; A. Louw^I

^IDepartment of Biochemistry, University of Stellenbosch, Private Bag X1, Matieland 7602, South Africa
^IIPost-Harvest & Wine Technology Division, ARC Infruitec-Nietvoorbij, Stellenbosch 7600, South Africa

 

 

---

ABSTRACT

Phyto-oestrogens mediate an oestrogenic effect through binding to the oestrogen receptor (ER) subtypes, ERa and ERß. Four commercially available Cyclopia (honeybush) species-C. intermedia, C. subternata, C. genistoides and C. sessiliflora-together with nine commercially obtainable polyphenols present in some or all of the species, were screened for phyto-oestrogenic activity, using a competitive whole-cell ER binding assay. Only naringenin, formononetin and luteolin were able significantly to displace ³H-E₂ from hERα, whereas luteolin, naringenin, formononetin, eriodictyol, narirutin and eriocitrin displaced ³H-E₂ from hERß. Mangiferin, hesperidin and hesperetin did not bind to either receptor subtype. To our knowledge, this is the first time that binding of eriodictyol, eriocitrin and narirutin to the hERß has been shown. Furthermore, both aqueous and methanol extracts from three independent harvestings of each Cyclopia species were screened. The results suggest that C. genistoides and C. subternata display significant phyto-oestrogenic activity and that methanol extracts from 'unfer-mented' (unoxidized) plant material generally display greater activity. Great variation exists within a species, however, with one C. genistoides harvesting displacing ³H-E₂ from both ER subtypes, while another harvesting displaced ³H-E₂ from only hERß, and a third did not displace ³H-E₂ from either receptor subtype.

---

 

 

“Full text available only in PDF format”

 

 

References

1. Kies P (1951). Revision of the genus Cyclopia and notes on some other sources of bush tea. Bothalia 6, 161-176.         [ Links ]

2. Du Toit J. and Joubert E. (1998). The effect of pretreatment on the fermentation of honeybush tea (Cyclopia maculata). J. Sci. Food Agric. 76, 537-545.         [ Links ]

3. De Nysschen A.M., Van Wyk B.E., Van Heerden F.R. and Schutte A.L. (1996). The major phenolic compounds in the leaves of Cyclopia species (honeybush tea). Biochem. Syst. Ecol. 24, 243-246.         [ Links ]

4. Ferreira D., Kamara B.I., Brandt E.V and Joubert E. (1998). Phenolic compounds from Cyclopia intermedia (honeybush tea). J. Agric. Food Chem. 46, 3406-3410.         [ Links ]

5. Kamara B.I., Brand D.J., Brandt E.V and Joubert E. (2004). Phenolic metabolites from honeybush tea (Cyclopia subternata). J. Agric. Food Chem. 52, 5391-5395.         [ Links ]

6. Joubert E., Otto F., Grüner S. and Weinreich B. (2003). Reversed-phase HPLC determination of mangiferin, isomangiferin and hesperidin in Cyclopia and the effect of harvesting date on the phenolic composition of C. genistoides. Eur. Food Res. Technol. 216, 270-273.         [ Links ]

7. Richards E.S. (2003). Antioxidant and antimutagenic activities of Cyclopia species and activity-guided fractionation of C. intermedia. M.Sc. thesis, University of Stellenbosch, South Africa.         [ Links ]

8. Marnewick J.L., Gelderblom W.C. and Joubert E. (2000). An investigation on the antimutagenic properties of South African herbal teas. Mutat. Res 471, 157-166.         [ Links ]

9. van der Merwe J.D. (2005). A comparative study on protection of Cyclopia spp. (honeybush), Aspalathus linearis (rooibos) and Camellia sinesis teas against Aflotoxin B1 induced mutagenesis in the Salmonella mutagenicity assay: Possible mechanisms involved. M.Sc. thesis, University of Stellenbosch, South Africa.         [ Links ]

10. Han D.H., Denison M.S., Tachibana H. and Yamada, K. (2002). Relationship between estrogen receptor-binding and estrogenic activities of environmental estrogens and suppression by flavonoids. Biosci. Biotechnol. Biochem. 66, 1479-1487.         [ Links ]

11. Breinholt V. and Larsen J.C. (1998). Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay. Chem. Res. Toxicol. 11, 622-629.         [ Links ]

12. Lee S.J., Chung H.Y., Maier C.G.A., Wood A.R., Dixon R.A. and Mabry T.J. (1998). Estrogenic flavonoids from Artemisia vulgaris L. J. Agric. Food Chem. 46, 3325-3329.         [ Links ]

13. Faure E.D., Chantre P. and Mares P. (2002). Effects of a standardized soy extract on hot flushes: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 9, 329-334.         [ Links ]

14. de Kleijn M.J.J., van der Schouw Y.T., Wilson PW.F., Grobbee D.E. and Jacques P.F. (2002). Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S. women: The Framingham Study. J. Nutr. 132, 276-282.         [ Links ]

15. Setchell K.D. and Lydeking-Olsen E. (2003). Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am. J. Clin. Nutr. 78, 593S-609.         [ Links ]

16. Jarry H., Metten M., Spengler B., Christoffel V. and Wuttke W. (2003). In vitro effects of the Cimicifuga racemosa extract BNO 1055. Maturitas 44, Suppl. 1, S31-S38.         [ Links ]

17. van de Weijer P.H. and Barentsen R. (2002). Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 42, 187-193.         [ Links ]

18. Dornstauder E., Jisa E., Unterrieder I., Krenn L., Kubelka W. and Jungbauer, A. (2001). Estrogenicactivityoftwostandardized red clover extracts (menoflavon (R)) intended for large scale use in hormone replacement therapy. J. Steroid Biochem. Mol. Biol. 78, 67-75.         [ Links ]

19. Eisenberg D.M., Davis R.B., Ettner S.L., Appel S., Wilkey S., Van Rompay M. and Kessler R.C. (1998). Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. J. Am. Med. Assoc. 280, 1569-1575.         [ Links ]

20. Duncan A.M., Phipps W. R. and Kurzer M.S. (2003). Phyto-oestrogens. Best Prac. Res. Clin. Endocrinol. Met. 17, 253-271.         [ Links ]

21. Tham D.M., Gardner C.D. and Haskell W.L. (1998). Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J. Clin. Endocrinol. Metab. 83, 2223-2235.         [ Links ]

22. Dixon R.A. and Ferreira D. (2002). Genistein. Phytochemistry 60, 205-211.         [ Links ]

23. Writing Group for the Women's Health Initiative Investigators Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial. (2002). J. Am. Med. Assoc. 288, 321-333.         [ Links ]

24. The Women's Health Initiative Steering Committee Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy: The Women's Health Initiative Randomized Controlled Trial (2004). J. Am. Med. Assoc. 291, 1701-1712.         [ Links ]

25. Adlercreutz H. (2002). Phyto-oestrogens and cancer. Lancet Oncol. 3, 364-373.         [ Links ]

26. Arena S., Rappa C., Del Frate E., Cenci S. and Villani C. (2002). A natural alternative to menopausal hormone replacement therapy. Phytoestrogens. Minerva Ginecol. 54, 53-57.         [ Links ]

27. Ewies A.A. (2002). Phytoestrogens in the management of the menopause: up-to-date. Obstet. Gynecol. Surv. 57, 306-313.         [ Links ]

28. Kotsopoulos D., Dalais F.S., Liang Y.L., McGrath B.P. and Teede H.J. (2000). The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric 3, 161-167.         [ Links ]

29. Gruber C.J., Tschugguel W., Schneeberger C. and Huber J.C. (2002). Production and actions of estrogens. N. Engl. J. Med. 346, 340-352.         [ Links ]

30. Khastgir G., Studd J., Holland N., Alaghband-Zadeh J., Fox S. and Chow J. (2001). Anabolic effect of estrogen replacement on bone in postmenopausal women with osteoporosis: histomorphometric evidence in a longitudinal study. J. Clin. Endocrinol. Metab. 86, 289-295.         [ Links ]

31. Mendelsohn M.E. and Karas R.H. (1999). The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340, 1801-1811.         [ Links ]

32. Liao D.Z., Pantazis C.G., Hou X. and Li S.A. (1998). Promotion of estrogen-induced mammary gland carcinogenesis by androgen in the male noble rat: Probable mediation by steroid receptors. Carcinogenesis 19, 2173-2180.         [ Links ]

33. Pike M.C., Peters R.K., Cozen W., Probst-Hensch N.M., Felix J.C., Wan P.C. and Mack T.M. (1997). Estrogen-progestin replacement therapy and endometrial cancer. J. Natl Cancer Inst. 89, 1110-1116.         [ Links ]

34. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E.,Pettersson K.,Warner M. and Gustafsson J.A. (2001). Mechanisms of estrogen action. Physiol. Rev. 81, 1535-1565.         [ Links ]

35. Green S., Walter P., Kumar V., Krust A., Bornert J.M., Argos P. and Chambon P. (1986). Human oestrogen receptor CDNA: sequence, expression and homology to V-Erb-A. Nature 320, 134-139.         [ Links ]

36. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S. and Gustafsson J.A. (1996). Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl Acad. Sci. USA 93, 5925-5930.         [ Links ]

37. Paech K., Webb P., Kuiper G.G., Nilsson S., Gustafsson J.A., Kushner P.J. and Scanlan TS. (1997). Differential ligand activation of estrogen receptors ERα and ERß at AP1 sites. Science 277, 1508-1510.         [ Links ]

38. Liu M.M., Albanese C., Anderson C.M., Hilty K., Webb P., Uht R.M., Price R.H., Pestell R.G. and Kushner P.J. (2002). Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J. Biol. Chem. 277, 24353-24360.         [ Links ]

39. Lindberg M.K., Moverare S., Skrtic S., Gao H., Dahlman-Wright K., Gustafsson J.A. and Ohlsson C. (2003). Estrogen receptor (ER)a reduces ERb-regulated gene transcription, supporting a 'Ying Yang' relationship between ERα and ERß in mice. Mol. Endocrinol. 17, 203-208.         [ Links ]

40. Kuiper G.G.J.M., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B. and Gustafsson J.A. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor ß. Endocrinology 139, 4252-4263.         [ Links ]

41. Morito K., Hirose T., Kinjo J., Hirakawa T., Okawa M, Nohara T., Ogawa S., Inoue S., Muramatsu M. and Masamune Y. (2001). Interaction of phyto-estrogens with estrogen receptors α and ß. Biol. Pharm. Bull. 24, 351-356.         [ Links ]

42. Mueller S.O., Simon S., Chae K., Metzler M. and Korach K.S. (2004). Phyto-estrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor a (ERß) and ERß in human cells. Toxicol. Sci. 80, 14-25.         [ Links ]

43. Mackerness S.A.H. (1999). Effects of UV-Bradiation on plants: gene expression and signal transduction pathways. In Plant Responses to Environmental Stress, eds M.F. Smallwood and C.M. Calvert. BIOS Scientific Publishers, Oxford.         [ Links ]

44. Swinny E. E. and Ryan K.G. (2005). Red clover Trifolium pratense L. phyto-estrogens: UV-B radiation increases isoflavone yield, and postharvest drying methods change the glucoside conjugate profiles. J. Agric. Food Chem. 53, 8273-8278.         [ Links ]

45. Singleton V.L. and Rossi J.A. Jr. (1965). Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am. J. Enol. Vitic. 16, 144-158.         [ Links ]

46. Sathya G., Yi P., Bhagat S., Bambara R.A., Hilf R. and Muyan M. (2002). Structural regions of ERalpha critical for synergistic transcriptional responses contain co-factor interacting surfaces. Mol. Cell. Endocrinol. 192, 171-185.         [ Links ]

47. Sambrook J. and Fritsch E.F. (1989). In Maniatus,MolecularCloning,aLaboratory Manual. CSHL Press, Woodbury, New York.         [ Links ]

48. Bradford M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.         [ Links ]

49. Beck V., Rohr U. and Jungbauer A. (2005). Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy? J. Steroid Biochem. Mol. Biol. 94, 499-518.         [ Links ]

50. Hubbe M.E. (2000). Evaluation of antioxidant and free radicals cavenging activities of honey bushtea (Cyclopia). M.Sc. thesis, University of Stellenbosch, South Africa.         [ Links ]

51. Kamara B.I., Brandt E.V., Ferreira D. and Joubert E. (2003). Polyphenols from honeybush tea (Cyclopia Intermedia). J. Agric. Food Chem. 51, 3874-3879.         [ Links ]

52. Matthews J., Celius T., Halgren R. and Zacharewski T. (2000). Differential estrogen receptor binding of estrogenic substances: a species comparison. J. Steroid Biochem. Mol. Biol. 74, 223-234.         [ Links ]

53. Zava D.T., Blen M. and Duwe G. (1997). Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. Environ. Hlth Perspect. 105 Suppl. 3, 637-645.         [ Links ]

54. Strom A., Hartman J., Foster J.S., Kietz S., Wimalasena J. and Gustafsson J.A. (2004). Estrogen receptor inhibits 17-oestradiol-stimulated proliferation of the breast cancer cell line T47D. Proc. Natl Acad. Sci. USA 101, 1566-1571.         [ Links ]

55. Paruthiyil S., Parmar H., Kerekatte V, Cunha G.R., Firestone G.L. and Leitman D.C. (2004). Estrogen receptor ß inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res. 64, 423-428.         [ Links ]

56. Weihua Z., Saji S., Makinen S., Cheng G., Jensen E.V., Warner M. and Gustafsson J.A. (2000). Estrogen receptor (ER) beta , a modulator of ERalpha in the uterus. Proc. Natl Acad. Sci. USA 97, 5936-5941.         [ Links ]

57. Weihua Z., Makela S., Andersson L.C., Salmi S., Saji S., Webster J.I., Jensen E.V., Nilsson S., Warner M. and Gustafsson J.A. (2001). A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc. Natl Acad. Sci. USA 98, 6330-6335.         [ Links ]

58. Miksicek R.J. (1995). Estrogenic flavonoids: structural requirements for biological activity. Proc. Soc. Exp. Biol. Med. 208, 44-50.         [ Links ]

59. Ahn E.M., Nakamura N., Akao T, Nishihara T and Hattori M. (2004). Estrogenic and antiestrogenic activities of the roots of Moghania philippinensis and their constituents. Biol. Pharm. Bull. 27, 548-553.         [ Links ]

 

 

Received 24 April 2006.
Accepted 25 September 2006.

 

 

* Author for correspondence. E-mail: al@sun.ac.za